Tamayo Uechi

Dr. Tamayo Uechi


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2008 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
TUTamayo Uechi
Tamayo Uechi
YNYukari Nakajima
Yukari Nakajima
ACAnirban Chakraborty
Anirban Chakraborty
HTHidetsugu Torihara
Hidetsugu Torihara
SHSayomi Higa
Sayomi Higa
NKNaoya Kenmochi
Naoya Kenmochi
Ribosomes are responsible for protein synthesis in all cells. Ribosomal protein S19 (RPS19) is one of the 79 ribosomal proteins (RPs) in vertebrates. Heterozygous mutations in RPS19 have been identified in 25% of patients with Diamond-Blackfan anemia (DBA), but the relationship between RPS19 mutations and the pure red-cell aplasia of DBA is unclear. In this study, we developed an RPS19-deficient zebrafish by knocking down rps19 using a Morpholino antisense oligo. The RPS19-deficient animals showed a dramatic decrease in blood cells as well as deformities in the head and tail regions at early developmental stages. These phenotypes were rescued by injection of zebrafish rps19 mRNA, but not by injection of rps19 mRNAs with mutations that have been identified in DBA patients. Our results indicate that rps19 is essential for hematopoietic differentiation during early embryogenesis. The effects were specific to rps19, but knocking down the genes for three other RPs, rpl35, rpl35a and rplp2, produced similar phenotypes, suggesting that these genes might have a common function in zebrafish erythropoiesis. The RPS19-deficient zebrafish will provide a valuable tool for investigating the molecular mechanisms of DBA development in humans.

28 February 2006 in BMC Genomics
Verified
Journal Article
Open access
PDF file
KIKyota Ishii
Kyota Ishii
TWTakanori Washio
Takanori Washio
TUTamayo Uechi
Tamayo Uechi
MYMaki Yoshihama
Maki Yoshihama
NKNaoya Kenmochi
Naoya Kenmochi
MTMasaru Tomita
Masaru Tomita
Background: The ribosome is a central player in the translation system, which in mammals consists of four RNA species and 79 ribosomal proteins (RPs). The control mechanisms of gene expression and the functions of RPs are believed to be identical. Most RP genes have common promoters and were therefore assumed to have a unified gene expression control mechanism. Results: We systematically analyzed the homogeneity and heterogeneity of RP genes on the basis of their expression profiles, promoter structures, encoded amino acid compositions, and codon compositions. The results revealed that (1) most RP genes are coordinately expressed at the mRNA level, with higher signals in the spleen, lymph node dissection (LND), and fetal brain. However, 17 genes, including the P protein genes (RPLP0, RPLP1, RPLP2), are expressed in a tissue-specific manner. (2) Most promoters have GC boxes and possible binding sites for nuclear respiratory factor 2, Yin and Yang 1, and/or activator protein 1. However, they do not have canonical TATA boxes. (3) Analysis of the amino acid composition of the encoded proteins indicated a high lysine and arginine content. (4) The major RP genes exhibit a characteristic synonymous codon composition with high rates of G or C in the third-codon position and a high content of AAG, CAG, ATC, GAG, CAC, and CTG. Conclusion: Eleven of the RP genes are still identified as being unique and did not exhibit at least some of the above characteristics, indicating that they may have unknown functions not present in other RP genes. Furthermore, we found sequences conserved between human and mouse genes around the transcription start sites and in the intronic regions. This study suggests certain overall trends and characteristic features of human RP genes.

9 October 2019 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
TUTamayo Uechi
Tamayo Uechi
NKNaoya Kenmochi
Naoya Kenmochi
Diamond-Blackfan anemia (DBA) is a rare bone marrow failure syndrome characterized by red blood cell aplasia. Currently, mutations in 19 ribosomal protein genes have been identified in patients. However, the pathogenic mechanism of DBA remains unknown. Recently, several DBA models were generated in zebrafish (Danio rerio) to elucidate the molecular pathogenesis of disease and to explore novel treatments. Zebrafish have strong advantages in drug discovery due to their rapid development and transparency during embryogenesis and their applicability to chemical screens. Together with mice, zebrafish have now become a powerful tool for studying disease mechanisms and drug discovery. In this review, we introduce recent advances in DBA drug development and discuss the usefulness of zebrafish as a disease model.

1 January 2018 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
ACAnirban Chakraborty
Anirban Chakraborty
TUTamayo Uechi
Tamayo Uechi
YNYukari Nakajima
Yukari Nakajima
HGHanna T. Gazda
Hanna T. Gazda
MOMarie-Francoise O'Donohue
Marie-Francoise O'Donohue
NKNaoya Kenmochi
Naoya Kenmochi